Does MYCOPHENOLATE MOFETIL Cause Bronchopulmonary aspergillosis? 702 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 702 reports of Bronchopulmonary aspergillosis have been filed in association with MYCOPHENOLATE MOFETIL (Mycophenolate mofetil). This represents 0.9% of all adverse event reports for MYCOPHENOLATE MOFETIL.
702
Reports of Bronchopulmonary aspergillosis with MYCOPHENOLATE MOFETIL
0.9%
of all MYCOPHENOLATE MOFETIL reports
256
Deaths
378
Hospitalizations
How Dangerous Is Bronchopulmonary aspergillosis From MYCOPHENOLATE MOFETIL?
Of the 702 reports, 256 (36.5%) resulted in death, 378 (53.8%) required hospitalization, and 142 (20.2%) were considered life-threatening.
Is Bronchopulmonary aspergillosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MYCOPHENOLATE MOFETIL. However, 702 reports have been filed with the FAERS database.
What Other Side Effects Does MYCOPHENOLATE MOFETIL Cause?
Off label use (13,474)
Drug ineffective (7,729)
Product use in unapproved indication (5,910)
Diarrhoea (3,628)
Cytomegalovirus infection (3,278)
Pneumonia (3,017)
Pyrexia (2,927)
Condition aggravated (2,883)
Covid-19 (2,706)
Transplant rejection (2,500)
What Other Drugs Cause Bronchopulmonary aspergillosis?
TACROLIMUS (968)
PREDNISONE (967)
DEXAMETHASONE (854)
CYCLOPHOSPHAMIDE (824)
METHYLPREDNISOLONE (794)
PREDNISOLONE (704)
RITUXIMAB (606)
CYCLOSPORINE (583)
METHOTREXATE (553)
CYTARABINE (550)
Which MYCOPHENOLATE MOFETIL Alternatives Have Lower Bronchopulmonary aspergillosis Risk?
MYCOPHENOLATE MOFETIL vs MYCOPHENOLATE MOFETIL\MYCOPHENOLATE MOFETIL
MYCOPHENOLATE MOFETIL vs MYCOPHENOLIC ACID
MYCOPHENOLATE MOFETIL vs MYFORTIC
MYCOPHENOLATE MOFETIL vs MYRBETRIQ
MYCOPHENOLATE MOFETIL vs NABILONE